ClinicalTrials.gg
TerminatedNCT04652687Updated Oct 6, 2026

VIA Disc NP Registry

An observational study in Discogenic Pain, Back Pain and Back Pain, Low, sponsored by VIVEX Biologics, Inc.. Terminated at 32 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-06.

Primary conditionLow Back PainRegistry: Back PainReclassifiedWhy we changed it
Registry
Back Pain — the first condition term the registry derived for this study.
ClinicalTrials.gg
Low Back Pain
Why
  1. The study's listed conditions name Low Back Pain, a narrower term within Back Pain.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by VIVEX Biologics, Inc. · Observational

How we know

Why this study was terminated
Sponsor decision.
Updated Oct 6, 20262 sites added2 sites removedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
83
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 712 studies in Low Back Pain with a site in United States — 100 open to participants now, 126 under way, 3 of them phase 3. Low Back Pain · United States.

Enrollment
44th of 85
83 · median 90
Started
2020
with 31 others
Observational
87 of 712
19 open now
Registered
511th of 712
by date

Among the 712 studies in Low Back Pain with a site in United States, this one is the 44th largest by enrollment of the 85 observational ones that give a count, is one of 32 that started in 2020, is one of 87 observational ones, and was the 511th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

100 of the 712 studies in Low Back Pain with a site in United States are open now. Recruiting first, the newest first:

95 more — sign in →

All 100 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 712 studies in Low Back Pain with a site in United States, or all of them as a file.
02

Study summary

Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.

Read the detailed description

The Registry is intended to collect data for patients having received treatment with VIA Disc NP.

03

Conditions studied

  • Discogenic Pain
  • Back Pain
  • Back Pain, Low

Browse trials for

Keywords

  • back pain
04

In context

Low Back Pain Reclassified

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

This study's enrollment of 83 is below the median of 100 across 484 observational studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

VIVEX Biologics, Inc. is the lead sponsor of 9 studies on the registry; 1 is open to participants now.

Compared within Low Back Pain, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Back Pain. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Registry will include at least 10,000 patients diagnosed with and treated for back pain across approximately 200 selected sites.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years of age or older
  • Understand and sign the form (as applicable)
  • VIA Disc NP injection is scheduled for 1 or more levels

Exclusion criteria

Exclusion Criteria:

  • VIA Disc NP injection is not performed
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

06

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
83 participants (actual)
Target follow-up
36 Months
Patient registry
Yes

Groups and cohorts

  • VIA Disc NP

    Patients meeting study criteria receiving Vivex VIA Disc NP injection as treatment

    Other: VIA Disc NP (HCT/P)

Interventions

  • OtherVIA Disc NP (HCT/P)

    VIA Disc NP - Allograft tissue injection

07

What researchers measure

Primary outcomes

  1. Patient self-reporting of daily function

    Change in scores from Oswestry Disability Index (ODI). An index comprising of ten categories of function to quantify disability due to back pain.

    Time frame: 1, 3, 6, 12, 24, & 36 months

  2. Patient self-reported back pain

    Change in Numeric Rating Scale (NRS) scores. Eleven point pain scale used for patient self-reporting of back pain, which ranges from 0 (no pain) to 10 (the worst pain imaginable).

    Time frame: 1, 3, 6, 12, 24, & 36 months

Secondary outcomes

  1. Patient self-reported mental health

    Change in patient reported anxiety and depression scores. Four question scale used for patient self-reporting of anxiety and depression which ranges from 0-2 (normal), mild (3-5), moderate (6-8), and severe (9-12).

    Time frame: 1, 3, 6, 12, 24, & 36 months

  2. Resource Utilization

    Patient reported assessment of healthcare and resources utilized questions to treat ongoing back pain post treatment.

    Time frame: 1, 3, 6, 12, 24, & 36 months

08

Study locations

32 sites
  • Gateway Pain Solutions
    Mesa, Arizona 85206, United States
  • Source Healthcare
    Santa Monica, California 90403, United States
  • Interventional Pain Management
    Walnut Creek, California 94598, United States
  • MD Pain
    Englewood, Colorado 80112, United States
  • Western Rockies Interventional Pain Specialists
    Grand Junction, Colorado 81505, United States
  • The Denver Spine & Pain Institute
    Greenwood Village, Colorado 80111, United States
  • International Spine, Pain & Performance Center
    Washington D.C., District of Columbia 20006, United States
  • The Orthopedic Institute
    Gainesville, Florida 32607, United States
  • Southwest Florida Pain Center
    Port Charlotte, Florida 33948, United States
  • FAST MD
    Tampa, Florida 33609, United States
  • Florida Spine & Pain Specialists
    Tampa, Florida 33614, United States
  • Florida Pain Medicine
    Wesley Chapel, Florida 33544, United States
  • Orthopaedic Research Foundation
    Indianapolis, Indiana 46278, United States
  • Anesthesiology & Pain Consultants
    Lafayette, Louisiana 70508, United States
  • Interventional Pain Specialists
    Opelousas, Louisiana 70570, United States
  • Michigan Interventional Pain Center
    Brownstown, Michigan 48183, United States
  • Forest Health
    Ypsilanti, Michigan 48198, United States
  • Nevada Advanced Pain Specialists
    Reno, Nevada 89511, United States
  • Ainsworth Institute of Pain Management
    New York, New York 10022, United States
  • Premier Pain Solutions
    Asheville, North Carolina 28803, United States
  • Crystal Coast Pain Management
    New Bern, North Carolina 28560, United States
  • Premier Pain
    Loveland, Ohio 45140, United States
  • Invictus Healthcare System
    Tulsa, Oklahoma 74133, United States
  • Center for Interventional Pain Spine
    Chadds Ford, Pennsylvania 19317, United States
  • Atlantic Coast Pain Management
    Conway, South Carolina 29526, United States
  • Southeastern Spine Institute
    Mt. Pleasant, South Carolina 29464, United States
  • Specialist in Pain Management
    Chattanooga, Tennessee 37404, United States
  • Vertex Spine
    Franklin, Tennessee 37067, United States
  • Ortho Spine Surgery Institute
    North Richland Hills, Texas 76182, United States
  • MD SpineCare and DC Medical Solutions
    San Antonio, Texas 78229, United States
  • Advanced Spine and Pain Center
    San Antonio, Texas 78258, United States
  • The Sprintz Center for Pain
    Shenandoah, Texas 77384, United States
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2020 to primary completion in Mar 2024, 46 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2020
First posted
Dec 3, 2020
StartActual
May 3, 2020
Primary completionActual
Mar 5, 2024
CompletionActual
Mar 5, 2024
Last update
Oct 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
2 sites added, 2 sites removed
Show 2 added (2 United States)
  • International Spine, Pain & Performance Center · Washington D.C., United States
  • Southeastern Spine Institute · Mt. Pleasant, United States
Show 2 removed
  • International Spine, Pain & Performance Center · Washington, United States
  • Southeastern Spine Institute · Mount Pleasant, United States
Oct 6, 2026
Show all 1 update
  1. Oct 6, 2026
    2 sites added, 2 sites removed
    Show 2 added (2 United States)
    • International Spine, Pain & Performance Center · Washington D.C., United States
    • Southeastern Spine Institute · Mt. Pleasant, United States
    Show 2 removed
    • International Spine, Pain & Performance Center · Washington, United States
    • Southeastern Spine Institute · Mount Pleasant, United States
    + 3 other changes: index terms, verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT04652687
Lead sponsor
VIVEX Biologics, Inc.
Responsible party
Sponsor
First posted
Dec 3, 2020
Start date
May 3, 2020
Primary completion
Mar 5, 2024
Completion
Mar 5, 2024
Last update
Oct 6, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion